We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
RPI 17-Aag , 5 Milligrams
17(Allylamino)-17-demethoxygeldanamycin
75747-14-7
585.7
C31H43N3O8
DMSO, Methanol
-20°C
17-AAG (17-Allylamino-17-demethoxygeldanamycin) is a synthetic derivative of geldanamycin. Like geldanamycin, 17-AAG is recognized for its role as an inhibitor of heat shock protein 90 (Hsp90), a molecuLar chaperone involved in protein folding and stabilization.
It is often used as a tool to study Hsp90-dependent processes. By inhibiting Hsp90, 17-AAG impacts the stability and function of various client proteins, many of which are involved in critical celluLar processes, including signal transduction and cell cycle reguLation. Similar to geldanamycin, 17-AAG is particuLarly relevant in cancer research, as Hsp90 is often crucial for the stability of oncoproteins.
Researchers use 17-AAG to explore the molecuLar mechanisms of Hsp90 inhibition, with potential applications in understanding cancer biology and developing therapeutic strategies.
0 lbs
1.25 x 1.75 x 1.25
Research or further manufacturing use only, not for food or drug use.
| SKU | RPI-A20045-0.005 |
|---|---|
| Featured | No |
| Supplier Part Number | A20045-0.005 |
| UM | EA |
| UNSPSC | 51102800 |
| Manufacturer | RPI |
| CountryOfOrigin | United States |
| ProductLine | RPI |
| Qty | 1 |
| MinOrderQty | 1 |
| Width | 1.25 |
| Depth | 1.25 |
| Height | 1.75 |
| Weight | 7.000000 |
| Lead Time | 3 |
| Hazardous | N |
| CAS Number | 75747-14-7 |
| ACT Ecolabel | No |